Noom Launches Free GLP-1 Companion Program to Extend Weight-Loss Support
Event summary
- Noom launched a free GLP-1 Companion program on June 24, 2026, available to anyone taking GLP-1 medications.
- The program includes tools for protein guidance, side-effect management, muscle preservation, and habit formation.
- Noom claims users on GLP-1s lose 1.4x more weight with its support compared to medication alone.
- Preliminary data shows Noom members regained less than 2% body weight 12 months after stopping GLP-1 treatment.
The big picture
Noom's free GLP-1 Companion program targets a critical gap in weight-loss maintenance as most patients stop GLP-1 therapy within a year. The move positions Noom as a key player in extending the efficacy of pharmaceutical interventions through behavioral support, aligning with broader trends in preventive care and longevity medicine.
What we're watching
- Adoption Dynamics
- How quickly providers will integrate the free GLP-1 Companion into their patient care protocols.
- Outcome Validation
- Whether Noom's preliminary data on weight maintenance post-GLP-1 discontinuation holds up under further scrutiny.
- Market Positioning
- The pace at which Noom can differentiate itself in the crowded GLP-1 support space.
Related topics